SBIR and STTR Success Story for
Clinical Tools, Inc.

(Information Posted/Updated on 05/10/2012)

Clinical Tools, Inc.
1506 E. Franklin Street
Chapel Hill, NC  27514

Contact:    Mary Metcalf, PhD
Phone:      919-960-8118
Fax:          866-359-1271
Web Site:

Project Title:  Education on Opiate Addiction and Treatment
Related Award(s):  R44DA012066 and HHSN271200655304C
Technology Developed:
We developed an online buprenorphine treatment training program on ( The training meets the Drug Enforcement Administration's (DEA) educational requirement for a waiver to prescribe buprenorphine. Software developed with the funding allows the site to provide an extensive resource database; buprenorphine prescribers may also create individualized webpages to support their practice.

Key Words:  Buprenorphine treatment, opioid dependence, buprenorphine training, Data 2000 waiver, ffice-based opioid treatm, prescription opioid misus.
Uses of Technology/Products/Service:
Using funding from two SBIR awards, Clinical Tools created a product with both practice planning and core training components. ( includes resources, practice advisers, practice promotion, and practice to patient communication tools to help physicians establish an effective office-based opioid treatment (OBOT) practice to manage patients who are prescribed buprenorphine. We continue to expand, update and grow the website.

In partnership with the American Society of Addiction Medicine (ASAM), the training program fulfills the physician training requirements of the Drug Addiction Treatment Act of 2000; physician learners receive a DEA waiver to prescribe buprenorphine to patients with opioid addiction. Physicians who complete the program are also eligible for 9 hours of AMA PRA Category 1 Credit™. 

Benefit to Company:
Clinical Tools, in partnership with ASAM, is one of only four providers qualified to provide training to physicians in the use of buprenorphine. We have led the movement toward online buprenorphine waiver training (which is now the only method delivered). Clinical Tools currently provides about 1/3rd of all buprenorphine DATA 2000 waiver training through Our successful partnership with ASAM allowed us to once again partner with them on another product, We also have partnered with the Association for Medical Education and Research in Substance Abuse (AMERSA) organization to disseminate a third product,

How Product Was Commercialized:
Clinical Tools, Inc. is partnering with the American Society of Addiction Medicine (ASAM) to disseminate ( uses viral marketing and word-of-mouth to grow the audience, and is fully self-supporting (no pharmaceutical company support is involved).

Other Comments Related to Company's Success Story:
In 2007, Clinical Tools, Inc. was awarded an SBIR Tibbetts award for exemplary achievement due to the success of our professional continuing education materials.

Past R&D and/or Sales from this Project:   $$700,000
Estimated Future Annual R&D and/or Sales from this Project:   $$200,000